Views & Analysis Ensuring access: how to help patients seeking experimental t... The impact of the debate on the Right-to-Try laws in the US and what needs to be done to improve access to innovative drugs.
Views & Analysis Going beyond CSR to reach ‘the two billion’ Impact of putting access to medicine at the core of pharma businesses.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends